Catalyst Biomedica - Research and Technology

Catalyst BioMedica was formed to facilitate the translation of fundamental biomedical chemistry research into innovative products and technologies to meet global healthcare needs. Catalyst Biomedica was established by the Wellcome Trust as a business development subsidiary to work with scientists and their host research organizations and institutions.

Catalyst BioMedica was established with the goal of providing a complementary resource to professionals involved in university intellectual property and technology transfer. The organization was tasked with the protection of patent and other intellectual property assets. The organization sought to administer the funding and patenting of selected applied research and technology projects. Catalyst BioMedica undertook an important objective to promote the delivery of benefits for healthcare while ensuring that the benefits of new technologies be shared equitably among those researchers who serve as engines of innovation, and those who fund and facilitate the transfer of new technology to the commercial sector.

• HOME
• LINKS